16.2 Sponsor, Investigator and Service-Provider Roles

Sponsor, Investigator and Service-Provider Roles

A trial can involve a sponsor, CRO, investigator/institution, laboratories, imaging vendors, data managers, medical monitors and independent committees. E6(R3) expects responsibilities to be clear and documented. A task sent to another organisation does not disappear from oversight, and a service contract does not automatically give every employee authority to make clinical or regulatory decisions.

The sponsor initiates and manages the trial and maintains oversight of sponsor activities transferred to service providers. The investigator is responsible for site conduct and oversight of delegated site activities. A CRO can perform specified sponsor tasks, including monitoring, under the documented arrangement. The CRA works within that allocation; being the sponsor's representative is not authority to rewrite site source data or prescribe participant care.

Distinguish performance from accountability

A qualified coordinator may enter data, arrange visits and facilitate reporting. A pharmacist may manage product activities where permitted. A laboratory produces analytical results under its assigned role. Their work still needs suitable investigator or sponsor oversight according to whose responsibility is involved. Oversight should be proportionate to risk and supported by information, review and escalation.

For example, a sponsor outsources central laboratory testing. It should have an appropriate arrangement for the service, data transfer, quality issues and access to records. The investigator still needs timely relevant results for participant care and eligibility. If a critical result reaches a vendor dashboard but not the treating site, saying the laboratory contract was signed does not solve the safety failure.

Clinical and operational roles

Titles vary. Read the actual responsibility matrix, agreements and plans instead of assuming that every organisation uses the same job names. An exam question asks what the relevant person should do in the scenario, not what your employer happens to call that position.

Delegated and transferred activities

Document the activity, expected standard, responsible contact, reporting arrangements, access and essential-record retention. Clarify responsibility for subcontracted work as relevant. The sponsor or investigator needs enough information to oversee the service, including defects, significant noncompliance and important changes. Oversight is more than collecting an annual performance score.

When a provider changes, plan continuity of participant support, data integrity, product/supply handling and record access. A transition can create mismatched identifiers, duplicate accounts, missing files or unclear safety contacts. Preserve the prior records and verify the transferred information rather than treating a new vendor's contract date as proof that the handover succeeded.

Risk and issue escalation

The CRA should know whom to contact for urgent clinical concerns, product stability decisions, system defects and quality findings. Use the relevant function rather than routing every issue only to a project manager. A suspected unreported SAE may need immediate investigator/safety-team contact; a routine invoice question usually belongs in the contracts process. Document important decisions and ensure the recipient can act.

A service provider's response that an issue is outside its scope may reveal a gap in the responsibility allocation. Escalate until ownership is established; do not let the issue remain unowned because two contracts use different language. The sponsor and investigator should resolve the interface while protecting participants and maintaining reliable records.

A handoff example

A home-assessment provider records a concerning symptom but assumes the central database automatically alerts the site. The data manager assumes the provider calls the investigator. The symptom reaches a weekly listing several days later. Review the protocol instructions, consent/contact expectations, provider training, technical alert configuration and actual communication timestamps. Determine the participant impact with the responsible clinical team.

Correct the immediate gap and the interface: who recognises an urgent concern, which channel is used, who acknowledges receipt and what happens if acknowledgement fails. A new training slide alone may be inadequate if the system still gives no confirmation. Verify the revised process with appropriate evidence and retain its defined responsibilities.

Records supporting oversight

Relevant agreements, plans, qualifications, training, communications, monitoring and quality evidence should remain accessible to the responsible parties. A provider portal may be used during the study, but retention must survive its closure. Confidentiality and blinding apply to shared records. Appropriate access enables oversight; unrestricted copying can create a separate privacy or integrity problem.

Official sources

Checked October 18, 2026: ICH E6(R3), Principles and Annex 1, ACRP CCRA Exam Content Outline.